IBSA’s presence at CPhI Worldwide is now a certainty: what are the flagship products you will be presenting at this new Milan edition?
A. Taborelli: An event like CPhI Worldwide represents an extraordinary showcase and an opportunity to meet industry professionals that we don’t want to miss. If the forecasts are confirmed, this year’s edition will host over 60,000 visitors, 2,400 exhibitors, and representatives from more than 166 countries: a unique opportunity for a company like IBSA, which aims to expand into international markets, to showcase the excellence of its solutions. Among the products we will bring to this edition are primarily those in the osteoarticular area, particularly Sinovial HL and Sinogel, pre-filled syringes for intra-articular injection containing hybrid hyaluronic acid, indicated for the treatment of pain or reduced mobility due to degenerative conditions, post-traumatic conditions, and tendinopathies associated with joint disability. Then there is Ialuril prefill, pre-filled syringes indicated to re-establish the glycosaminoglycan layers of the urothelial vesical tissue in cases where their loss can cause frequent and recurr ...